Arkolith/Insider Trading/EYPT/Form 4

Ribeiro Ramiro

Chief Medical OfficerEyePoint Pharmaceuticals, Inc. (EYPT) · full profile →Form 4 · filed Nov 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$32K
Net Open-Market Flow
-$32K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 11, 2025Sell(S)3K$11.61$32K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002013623-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML